COVID-19 – Guillain-Barre Syndrome

Angie Szumlinski
|
February 10, 2021
Image

Reports of Guillain-Barre syndrome (GBS) have emerged during the Coronavirus disease 2019 (COVID-19) pandemic. An epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS. Early reports identified neurological symptoms of COVID-19 infection as fever, headache anosmia, and dysgeusia. Subsequently, COVID-19 infection has been associated with stroke, meningoencephalitis, acute disseminated encephalomyelitis, and Guillain-Barre syndrome (GBS).

Although it is profoundly difficult to prove no link in a rare disease, the study does not support any significant causal link between COVID-19 infection and GBS.  If you have ever cared for a resident with GBS, it is a frightening syndrome that can lead to ventilator dependence and/or death. It is good news that research was done that can put our minds at ease that there is likely no association. Stay the course, stay strong, stay well, mask up and stay tuned.


Related Posts

Image showing a coffee cup.
Angie Szumlinski
|
January 10, 2025

Angie’s Weekly Roundup

Image of doctor looking at brain scans.
Angie Szumlinski
|
January 10, 2025

Delayed Intracranial Hemorrhage in Seniors